Legacy Education (LGCY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
25 Sep, 2026Company overview and market positioning
Operates six nationally accredited campuses in California, focusing on affordable, high-demand allied healthcare, veterinary, and business programs with 2,768 enrolled students as of December 31, 2024.
Achieved 79% graduation rate, 78% placement rate, and 79% NCLEX pass rate, with a 2% monthly student attrition rate.
Programs are designed for high ROI, shorter durations, and strong alignment with employer needs, leveraging hybrid and interactive distance learning models.
Strategic campus locations target areas with high job growth and address gaps left by traditional community colleges.
Growth strategy and expansion
Pursues organic growth through new program development, cross-program integration, and re-enrollment opportunities.
Expands via accretive acquisitions, with recent additions including Contra Costa Medical Career College, contributing to a 25% four-year enrollment CAGR.
Top five programs by enrollment represent 65% of total, with strong re-enrollment pathways and experiential extern sites.
36% of current enrollment attributed to successful M&A activities, with an active pipeline for future acquisitions.
Financial performance and key metrics
Reported $52.7M in LTM revenue (33% YoY growth), $9.9M LTM adjusted EBITDA (87% YoY growth), and $16.9M in cash as of December 31, 2024.
Student acquisition cost is $2K, generating over 10x annual revenue per student ($23K ARPS).
Q2 FY25 revenue reached $13.6M (29% YoY growth), with 2,768 ending enrollment (45% YoY growth).
Maintains strong liquidity and working capital ($18.9M), supporting ongoing operations, capex, and M&A.
Latest events from Legacy Education
- Record enrollment lifted revenue, while growth costs and a legal settlement cut earnings.LGCY
Q1 2027 - Six director nominees and the FY2027 auditor appointment go before shareholders.LGCY
Proxy filing - Six directors and the auditor face votes at a virtual Dec. 15, 2026 meeting.LGCY
Proxy filing - Record revenue, margin, and enrollment gains set the stage for growth via new programs and expansion.LGCY
Q4 2026 - 32% revenue growth and strong student outcomes drive expansion in accredited healthcare education.LGCY
Investor presentation - Q3 2026 revenue up 15% and net income up 7.5%, driven by enrollment and new programs.LGCY
Q3 2026 - Achieved 42% revenue growth and 17% enrollment growth, with strong student outcomes and robust liquidity.LGCY
Investor presentation - Q2 revenue up 40.7% and net income up 46%, driven by enrollment and acquisition growth.LGCY
Q2 2026 - Q3 revenue rose 50.7% and enrollment 49.8%, driven by CCMCC acquisition and strong demand.LGCY
Q3 2025